Top compounds associated with response to CABS1


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.025 0.5
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.027 0.5
mRNA AR-42 GDSC1000 pan-cancer AAC -0.022 0.5
mRNA PD173074 GDSC1000 pan-cancer AAC 0.026 0.5
mRNA BRD-K63431240 CTRPv2 pan-cancer AAC 0.026 0.5
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.024 0.5
mRNA SB-743921 CTRPv2 pan-cancer AAC -0.024 0.5
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.025 0.5
mRNA nelarabine CTRPv2 pan-cancer AAC -0.028 0.5
mRNA tacrolimus CTRPv2 pan-cancer AAC 0.026 0.5
Download CSV